Decision: Favourable

Decisions Table

Study Title:

A randomized, double-blind, placebo-controlled, Phase 2b trial with an open-label extension to determine the safety and efficacy of GH001 in patients with treatment-

  • NREC Code:

    22-NREC-CT-157

  • Decision:

    Favourable

  • Meeting Date:

    19/10/2022

  • Study Type:

    CT application

  • Principal Investigator:

    Dr John Kelly

  • PI Institution:

    Sheaf House, Tallaght Adult Mental Health Services, Dublin

  • Sponsor:

    GH Research Ireland Limited

Scroll to Top